Metoprolol Viatris

Metoprolol, the active ingredient in Metoprolol Viatris, is a beta‑adrenergic blocker presented as an oral tablet for oral use. It is employed to manage hypertension, angina pectoris, post‑myocardial infarction care, chronic heart failure, and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metoprolol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol acts on the cardiovascular system to control blood pressure and heart rhythm, addressing several related conditions.

- Hypertension: lowers systemic blood pressure by reducing cardiac output and renin release. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Post‑myocardial infarction: improves survival by limiting adverse cardiac remodeling. - Chronic heart failure: enhances ventricular function and reduces hospitalization risk. - Atrial and ventricular arrhythmias: stabilizes heart rhythm by slowing conduction through the AV node.

Metoprolol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate pain in the head. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea, abdominal discomfort.

Serious or Rare Side Effects: - Severe bradycardia: markedly slow heart rate requiring medical attention. - Heart block: impaired electrical conduction in the heart. - Hypotension: dangerously low blood pressure. - Bronchospasm: narrowing of airways, especially in patients with asthma. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Depression or mood changes: new or worsening depressive symptoms.

Before initiating Metoprolol therapy, several safety considerations should be reviewed.

- Blood pressure monitoring: ensure adequate control and avoid excessive hypotension. - Cardiac function assessment: evaluate heart rate and conduction abnormalities. - Respiratory caution: use carefully in patients with asthma or chronic obstructive pulmonary disease. - Dose adjustment: modify dosage in renal or hepatic impairment as recommended. - Discontinuation warning: avoid abrupt cessation to prevent rebound hypertension or tachycardia. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Metoprolol can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Verapamil or diltiazem: combined AV‑node blockade may cause severe bradycardia. - Clonidine withdrawal: abrupt stop can lead to hypertensive crisis. - Insulin or oral hypoglycemics: may mask hypoglycemia symptoms. - NSAIDs: can reduce antihypertensive effect of Metoprolol. - Strong CYP2D6 inhibitors (e.g., fluoxetine): increase Metoprolol plasma levels.

Moderate Interactions (Monitor Closely): - Amlodipine: additive blood‑pressure lowering effect. - Diuretics: may enhance hypotensive response. - SSRIs (e.g., sertraline): potential for modest heart‑rate reduction. - Potassium‑sparing diuretics: monitor serum potassium. - Anesthetic agents: may potentiate cardiovascular depression.